CRNX
Crinetics Pharmaceuticals Inc Earnings
$33.11
Earnings Summary
Revenue | $0Mn |
Net Profits | $-80.6Mn |
Net Profit Margins | -Inf% |
Crinetics Pharmaceuticals Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit fell -34.11% since last year same period to $-80.6Mn in the Q4 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -4.9% fall in its net profits since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.89 |
EPS Estimate Current Year | -0.89 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.89 - a 1.99% jump from last quarter’s estimates.
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.89.
Key Ratios
Earning Per Share (EPS) | -0.88 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) jumped 2.22% since last year same period to -0.88 in the Q4 2024. This indicates that the Crinetics Pharmaceuticals Inc has generated 2.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -0.81 | -0.93 | -14.81% |
2024-08-08 | -0.86 | -0.94 | -9.3% |
2024-11-12 | -0.91 | -0.96 | -5.49% |
2025-02-27 | -0.89 | -0.88 | 1.33% |
